LUV
66
-4
ADM
45
-2
AEP
64
3
CMCSA
52
2
VLO
42
2
AVGO
42
7
LEG
54
-3
TROW
59
-3
YUM
56
-2
DLTR
55
-3
EQT
56
6
SPG
50
2
ORLY
43
2
DE
43
-2
CINF
61
-5
ETN
59
2
CCI
38
2
D
41
6
ECL
59
-3
VTR
67
-2
LUV
66
-4
ADM
45
-2
AEP
64
3
CMCSA
52
2
VLO
42
2
AVGO
42
7
LEG
54
-3
TROW
59
-3
YUM
56
-2
DLTR
55
-3
EQT
56
6
SPG
50
2
ORLY
43
2
DE
43
-2
CINF
61
-5
ETN
59
2
CCI
38
2
D
41
6
ECL
59
-3
VTR
67
-2
Financhill
Back

Arcturus Therapeutics Holdings, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
30

ARCT
Arcturus Therapeutics Holdings, Inc.

Last Price:
$6.43
Seasonality Move:
-11.37%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$42.83
Seasonality Move:
0.59%
Sell
30
Arcturus Therapeutics Holdings, Inc. (ARCT) is a Sell

Is Arcturus Therapeutics Holdings, Inc. a Buy, Sell or Hold?

  • The current Arcturus Therapeutics Holdings, Inc. [ARCT] share price is $6.59. The Score for ARCT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.81. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ARCT Stock Price Chart

What is Arcturus Therapeutics Holdings, Inc.'s stock price today?

  • The Arcturus Therapeutics Holdings, Inc. share price today is $6.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight selling pressure.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.69 Sell
Relative Strength Index (14 RSI): 36.89 Sell
Chaikin Money Flow: -84315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.3 - 7.24) Sell
Bollinger Bands (100): (8.1 - 19.48) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.79 Buy
Relative Strength Index (14 RSI): 61.76 Buy
Chaikin Money Flow: 156273 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.4 - 40.3) Buy
Bollinger Bands (100): (17.9 - 35) Buy

ARCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.93 Sell
20-day SMA: 6.89 Sell
50-day SMA: 9.75 Sell
200-day SMA: 13.12 Sell
8-day EMA: 6.79 Sell
20-day EMA: 7.18 Sell
50-day EMA: 9.44 Sell
200-day EMA: 13.69 Sell

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.78 Buy
20-day SMA: 38.2 Buy
50-day SMA: 33.84 Buy
200-day SMA: 18.39 Buy
8-day EMA: 28.27 Buy
20-day EMA: 15.3 Buy
50-day EMA: 7 Buy
200-day EMA: 1.88 Buy

Arcturus Therapeutics Holdings, Inc. Earnings Growth & ARCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.43 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Arcturus Therapeutics Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):